pneumatic compression device for cancer patients

Pneumatic compression device for cancer patients manual#
Pneumatic compression device for cancer patients portable#

Healthcare professionals should facilitate communication among members of the lymphedema treatment team and the patient when problems are noted. Implications for Nursing: Patients using the Flexitouch system should be assessed for adherence to the prescribed treatment protocol and use of other self-care treatments.

Pneumatic compression device for cancer patients manual#

Participants' use of professional manual lymphatic drainage (MLD) therapy, self-MLD, and bandaging declined after they initiated use of the Flexitouch system.Ĭonclusions: Patients using the Flexitouch system were satisfied with the device and perceived it to be beneficial in management of their lymphedema. We tested potential differences in the effects on studies with more and less than 50 of participants with.

Studies evaluated included patients with cancer and without cancer. Includes trauma patients who did or did not undergo surgical procedures. Both groups were satisfied with the system, perceived it to be effective, and reported improvement in physical and emotional status. Includes cancer- and non-cancer-related procedures. Deep vein thrombosis (DVT) is a more deadly condition than many realize.

Pneumatic compression device for cancer patients portable#

The intermittent pneumatic compression device should be portable and capable of recording wear time.

Main Research Variables: Use of the Flexitouch system, treatment protocol adherence, participant satisfaction, and emotional and functional status.įindings: Participants without cancer were more adherent to the prescribed protocol. The intermittent pneumatic compression device should remain on for a minimum of 18 hours daily during the intraoperative and immediate postoperative period. Aetna considers intermittent pneumatic compression devices of the lower extremities medically necessary DME to stimulate circulation and reduce the chances of deep venous thromboses for members who are bedridden due to trauma, orthopedic surgery, neurosurgery or other circumstances preventing ambulation. A post-therapy survey was completed during the maintenance phase of the protocol. Participants received in-home education about device use, safety precautions, and the two-phase therapy protocol. Methods: A survey was completed before use of the Flexitouch system. Sample: 155 community-dwelling individuals with lymphedema: 93 with cancer-related lymphedema and 62 with noncancer-related lymphedema. Setting: Private homes in the continental United States and Alaska. Purpose/Objectives: To compare treatment protocol adherence, satisfaction, and perceived changes in emotional and functional status between patients with lymphedema with and without cancer using the home-based Flexitouch® (Tactile Systems Technology, Inc.) system for lymphedema self-care.ĭesign: Quasi-experimental, pre- and post-test design.